Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

By Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection

By Morse G.D.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of Intramuscular, Oral and Intravenous Aripiprazole in Healthy Subjects and in Patients with Schizophrenia

By Boulton David W.  

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite